VRT-1353385
- CAS No.
- 1616113-45-1
- Chemical Name:
- VRT-1353385
- Synonyms
- Sibofimloc;EB8018;CS-1707;VRT-1353385;Antibiotic-202;VRT 1353385;VRT1353385;Sibofimloc, 10 mM in DMSO;Antibiotic 202, Sibofimloc;Antibiotic-202, VRT-1353385;Sibofimloc (VRT-1353385, Antibiotic-202)
- CBNumber:
- CB32741568
- Molecular Formula:
- C35H39NO11
- Molecular Weight:
- 649.68
- MDL Number:
- MOL File:
- 1616113-45-1.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Sibofimloc | RPC11345 | 50mg | $828.5 |
| Sibofimloc | RPC11345 | 100mg | $1325 |
| Sibofimloc 99.70% | CS-5487 | 5mg | $108 |
| Sibofimloc 99.70% | CS-5487 | 10mg | $171 |
| Sibofimloc 99.70% | CS-5487 | 25mg | $311 |
| storage temp. | Store at -20°C |
|---|---|
| solubility | ≥ 20.2mg/mL in DMSO |
| form | Solid |
| color | White to off-white |
| FDA UNII | 00OF00QZC4 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
VRT-1353385 price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | RPC11345 | Sibofimloc | 1616113-45-1 | 50mg | $828.5 | 2026-06-05 | Buy |
| Biosynth | RPC11345 | Sibofimloc | 1616113-45-1 | 100mg | $1325 | 2026-06-05 | Buy |
| ChemScene | CS-5487 | Sibofimloc 99.70% | 1616113-45-1 | 5mg | $108 | 2026-06-04 | Buy |
| ChemScene | CS-5487 | Sibofimloc 99.70% | 1616113-45-1 | 10mg | $171 | 2026-06-04 | Buy |
| ChemScene | CS-5487 | Sibofimloc 99.70% | 1616113-45-1 | 25mg | $311 | 2026-06-04 | Buy |
VRT-1353385 Chemical Properties,Uses,Production
Uses
Sibofimloc (Antibiotic-202) is a first-in-class, gut-restricted, orally active FimH adhesion inhibitor extracted from patent WO2014100158A1, Compound Example 202. Sibofimloc has anti-bacterial infective activity. Sibofimloc is developed for inflammatory bowel disease (IBD)[1][2].
References
[1] Ramtohul, Yeeman K, et al. Preparation of mannose derivatives via coupling and click cycloaddition reactions for treating bacterial infections. From PCT Int. Appl. (2014), WO 2014100158 A1 20140626.
[2] W Reinisch, et al. P568 An open-label, multicenter, phase ib, pharmacokinetic (pk) and safety study of a fimh blocker, Sibofimloc (TAK-018/EB8018), in patients with Crohn’s disease (CD), Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020: S479–S480.
VRT-1353385 Preparation Products And Raw materials
Raw materials
Preparation Products
VRT-1353385 Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| Career Henan Chemica Co | +86-0371-86658258 +86-13203830695 | laboratory@coreychem.com | China | 30203 | 58 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6290 | 58 |
| BOC Sciences | 16314854226; +8616314854226 | inquiry@bocsci.com | United States | 19852 | 58 |
| Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 | sales@sarms4muscle.com | China | 10378 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6378 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; | support@targetmol.com | United States | 38999 | 58 |
| Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +86-15965530500 | nickzhang@hangyubiotech.com | China | 9935 | 58 |
| Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131885 | 58 |
| Shanghai Boyle Chemical Co., Ltd. | sales@boylechem.com | China | 2915 | 55 |
View Lastest Price from VRT-1353385 manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-04-20 | Sibofimloc
1616113-45-1
|
$33.00-129.00 | 99.11% | 10g | TargetMol Chemicals Inc. |
-

- Sibofimloc
1616113-45-1
- $33.00-129.00
- 99.11%
- TargetMol Chemicals Inc.





